UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling Journal article
Zhang, Yiming, Pan, Ruilin, Li, Kun, Cheang, Lek Hang, Zhao, Jing, Zhong, Zhangfeng, Li, Shaoping, Wang, Jinghao, Zhang, Xiaofang, Cheng, Yanmei, Zheng, Xiaofei, He, Rongrong, Wang, Huajun. HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling[J]. International Journal of Biological Sciences, 2024, 20(13), 5162-5190.
Authors:  Zhang, Yiming;  Pan, Ruilin;  Li, Kun;  Cheang, Lek Hang;  Zhao, Jing; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.3 | Submit date:2024/11/05
Atp5a1  Hspd1  Multiomics Analysis  Osteosarcoma  Oxidative Phosphorylation  Ubiquitination  
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy Journal article
Meng, Jialin, Jiang, Aimin, Lu, Xiaofan, Gu, Di, Ge, Qintao, Bai, Suwen, Zhou, Yundong, Zhou, Jun, Hao, Zongyao, Yan, Fangrong, Wang, Linhui, Wang, Haitao, Du, Juan, Liang, Chaozhao. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy[J]. iMeta, 2023, 2(4), e147.
Authors:  Meng, Jialin;  Jiang, Aimin;  Lu, Xiaofan;  Gu, Di;  Ge, Qintao; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:23.7/23.7 | Submit date:2024/01/10
Clear Cell Renal Cell Carcinoma  Immune Activation  Molecular Subtyping  Multiomics